Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K–12 Schools.

Autor: Kalu, Ibukunoluwa C, Zimmerman, Kanecia O, Goldman, Jennifer L, Mast, Dana Keener, Blakemore, Ashley M, Moorthy, Ganga, Boutzoukas, Angelique E, Campbell, Melissa M, Uthappa, Diya, DeLaRosa, Jesse, Potts, Jessica M, Edwards, Laura J, Selvarangan, Rangaraj, Benjamin, Daniel K, Mann, Tara K, Schuster, Jennifer E

Publikováno v: Journal of the Pediatric Infectious Diseases Society; Feb2023, Vol. 12 Issue 2, p64-72, 9p

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

Autor: Raja SM; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Guptill JT; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA.; Argenx BV, Ghent, Belgium., Mack M; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Peterson M; Fortrea Inc., Durham, North Carolina, USA., Byard S; Quotient Sciences, Alnwick, UK., Twieg R; Labcorp Bioanalytical Services, Indianapolis, Indiana, USA., Jordan L; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Rich N; Fortrea Inc., Durham, North Carolina, USA., Castledine R; Quotient Sciences, Alnwick, UK., Bourne S; Quotient Sciences, Alnwick, UK., Wilmshurst M; Quotient Sciences, Alnwick, UK., Oxendine S; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Avula SGC; Labcorp Bioanalytical Services, Indianapolis, Indiana, USA., Zuleta H; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Quigley P; Quotient Sciences, Alnwick, UK., Lawson S; Quotient Sciences, Alnwick, UK., McQuaker SJ; Quotient Sciences, Alnwick, UK., Ahmadkhaniha R; National Institute on Aging, Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA., Appelbaum LG; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Kowalski K; Labcorp Bioanalytical Services, Indianapolis, Indiana, USA., Barksdale CT; Labcorp Bioanalytical Services, Indianapolis, Indiana, USA., Gufford BT; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Awan A; Office of the Director, Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA., Sancho AR; Office of the Director, Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA., Moore MC; Drug Discovery and Development Program, Frederick National Laboratory, Fredrick, Maryland, USA., Berrada K; Drug Discovery and Development Program, Frederick National Laboratory, Fredrick, Maryland, USA., Cogan GB; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., DeLaRosa J; Duke Early Phase Research Unit, Duke University School of Medicine, Durham, North Carolina, USA., Radcliffe J; Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA., Pao M; Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA., Kennedy M; MRIGlobal, Kansas City, Missouri, USA., Lawrence Q; MRIGlobal, Kansas City, Missouri, USA., Goldfeder L; Office of the Director, Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA., Amanfo L; Office of the Director, Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA., Zanos P; Department of Psychology, University of Cyprus, Nicosia, Cyprus., Gilbert JR; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA., Morris PJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, USA., Moaddel R; National Institute on Aging, Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA., Gould TD; Department of Psychiatry, Pharmacology, and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Veterans Affairs Maryland Health Care System, Baltimore, Maryland, USA., Zarate CA Jr; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA., Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, USA.; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov; Vol. 116 (5), pp. 1314-1324. Date of Electronic Publication: 2024 Jul 25.